First Time Loading...

Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 51.03 USD -2.63% Market Closed
Updated: Jun 1, 2024

Tandem Diabetes Care Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tandem Diabetes Care Inc
Accounts Payable Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Tandem Diabetes Care Inc
NASDAQ:TNDM
Accounts Payable
$48.1m
CAGR 3-Years
20%
CAGR 5-Years
34%
CAGR 10-Years
37%
Becton Dickinson and Co
NYSE:BDX
Accounts Payable
$5.3B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Accounts Payable
$921m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
14%
Stryker Corp
NYSE:SYK
Accounts Payable
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Accounts Payable
$4.2B
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Payable
$194.4m
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
13%

See Also

What is Tandem Diabetes Care Inc's Accounts Payable?
Accounts Payable
48.1m USD

Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Accounts Payable amounts to 48.1m USD.

What is Tandem Diabetes Care Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
37%

Over the last year, the Accounts Payable growth was -13%. The average annual Accounts Payable growth rates for Tandem Diabetes Care Inc have been 20% over the past three years , 34% over the past five years , and 37% over the past ten years .